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Abstract We present silver nanoparticles as the new age
broad spectrum antibiotic. Siver nanoparticles exhibit
unique physical and chemical properties that make them
suitable for understanding their biological potential as
antimicrobials. In this study, we explored the antibacterial
activity of silver nanoparticles (TSC-AgNPs) and silver
nanoparticles doped with polyvinylpyrrolidone (PVP-
AgNPs) against Gram-negative and Gram-positive bacte-
ria, Escherichia coli (DH5a) and Staphylococcus aureus,
(ATCC 13709). Nucleation and growth kinetics during the
synthesis process of AgNPs were precisely controlled using
citrate (TSC) and further doped with polyvinylpyrrolidone
(PVP). This resulted in the formation of two different sized
nanoparticles 34 and 54 nm with PDI of 0.426 and 0.643.
The physical characterization was done by nanoparticle
tracking analysis and scanning electron microscopy, the
results of which are in unison with the digital light scat-
tering data. We found the bactericidal effect for both TSC-
AgNPs and PVP-AgNPs to be dose-dependent as deter-
mined by the minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) against E. coli
and S. aureus. Interestingly, we also observed that AgNPs
showed enhanced antimicrobial activity with a MIC of
26.75 and 13.48 lg/ml for E. coli and S. aureus, respec-
tively, while MBC for AgNPs are 53.23 and 26.75 lg/ml
for E. coli and S. aureus, respectively. Moreover, AgNPs
showed increased DNA degradation as observed confirm-
ing its higher efficacy as antibacterial agent than the PVP
doped AgNPs.
Keywords Silver nanoparticles  Citrate 
Polyvinylpyrrolidone  MIC  MBC
Introduction
The field of nanoscience is one of the most active areas of
research over the last 20 years. Nanotechnology is impor-
tant as miniaturization apparently improvises applications
in areas such as computing, sensors, and biomedical
research [1–3]. Nanoparticles exhibit completely new or
improved properties owing to their specific characteristics,
such as size, distribution, and morphology and therefore
used in a wide range of potential applications such as
medicine, cosmetics, renewable energies, environmental
remediation and biomedical devices. Silver nanoparticles
(AgNPs or nanosilver) have attracted increasing interest due
to their unique physical, chemical and biological properties
compared to their macro-scaled counterparts [4]. AgNPs
have distinctive physico-chemical properties, including a
high electrical and thermal conductivity, surface-enhanced
Raman scattering, chemical stability, catalytic activity and
nonlinear optical behavior [5]. These properties make them
of potential value in inks, microelectronics, and medical
imaging [6]. And also used in a diverse range of consumer
products, including plastics, soaps, pastes, food and textiles,
increasing their market value [7–9]. Nanosilver can be used
in a liquid form, such as a colloid (coating and spray) or
contained within a shampoo (liquid) and can also appear
embedded in a solid such as a polymer master batch or be
suspended in a bar of soap (solid). Nanosilver (AgNPs) is
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reported to possess anti-fungal [10], anti-inflammatory [11],
and anti-viral activity [12].
In recent years, resistance to antibiotics by pathogenic
bacteria and fungi has been increasing at an alarming rate
and has become a serious problem. For example, antibiotic-
resistant forms of pathogenic S. aureus (e.g. MRSA) is a
worldwide problem in clinical medicine [13] and also some
strains of E. coli (O157:H7) show resistance to a variety of
antibiotics such as ampicillin, kanamycin, sulfisoxazole,
streptomycin, tetracycline, ticarcillin, and so forth [14].
Silver has been thought of as a promising agent for over-
coming the resistance mechanism of antibacterial action on
a range of targets as compared to a specific site of action in
the case of antibiotics. The synergistic activity of AgNPs
coupled with antibiotics has been reported earlier [15].
Hence, silver-based nanoparticles could be effective bac-
tericidal materials as they will exhibit combined effects of
silver and antibacterial agents. In the present study, we
have compared the effects of two different stabilizing
agents i.e. citrate and polyvinyl pyrrolidone used in the
synthesis of AgNPs.
Materials and methods
Nutrient broth, agarose, nutrient agar and gentamycin were
purchased from Hi-Media Laboratories Pvt. Ltd. (Mumbai,
India). Glucose, sodium chloride and isopropanol were
purchased from CDH Lab New Delhi, India. Bromophenol
blue dye and EDTA were purchased from Sisco-Research
Lab Pvt Ltd. Tris buffer was purchased from Qualigens fine
chemicals (Mumbai, India and), Sodium Dodecyl Sulphate
(SDS) was purchased from Bio Rad Laboratories, sodium
hydroxide was purchased from E-Merck limited. Silver
nitrate (AgNO3, 99.99 %), tri-sodium citrate dihydrate
(C6H5O7Na32H2O, 99.99 %), sodium borohydride
(NaBH4, 98 %), polyvinylpyrrolidone (PVP;
Mw = 40,000) were purchased from Merck, USA. E. coli,
DH5a, was procured from the repository at PGI Chandi-
garh. Deionized water was used throughout the experiment.
Preparation of silver nanostructures
AgNPs were prepared according to a previously published
protocol by Fang et al. [16] by reduction of aqueous
AgNO3 with sodium citrate at boiling temperature. Briefly,
50 ml of 0.001 M AgNO3 was heated to 90 C. To this
solution, 5 ml of 1 % tri-sodium citrate was added drop
wise and the temperature was maintained under continuous
stirring. The reaction was allowed to take place until the
color changed to a pale yellow solution, which was then
cooled to room temperature. The mechanism of reaction
that could be expressed to prepare AgNPs is as follows:
4Agþ þ C6H5O7Na3 þ 2H2O
! 4Ago þ C6H5O7H3 þ 3Naþ þ Hþ þ O2 " ð1Þ
The synthesized AgNPs were doped using NaBH4 and
PVP as reducing and stabilizing agent, respectively. An
aqueous solution of tri-sodium citrate (0.5 ml, 30 mM) was
added into a flask (50 ml deionized water), and further
mixed with aqueous solution of AgNO3 (1 ml, 5 mM).
Freshly prepared NaBH4 aqueous solution (0.5 ml,
50 mM) was immediately added that gave a light yellow
color solution. In this solution, PVP (0.5 ml, 5 mg/ml,
Mw = 40,000) was added after 30 s at room temperature.
These PVP doped silver nanoparticles were marked PVP-
AgNPs.
Characterization of silver nanoparticles
UV–Vis spectroscopy
The appearance of yellow color in the reaction mixtures
was observed within minutes, an obvious indication for the
silver nanoparticle formation. Furthermore, the nanoparti-
cle synthesis was assured by monitoring the absorption
spectra in Cary 60 UV–Vis spectrophotometer, of the
synthesized colloidal solutions, against distilled water
using as blanks.
Dynamic light scattering
The sizes of AgNPs were observed by Zetasizer (Nano-ZS,
Malvern USA) [17]. Briefly, the sample solution was
diluted with deionized water to isolate all individual
nanoparticles from the aggregates to assess the distribution
based on size and surface charge of nanoparticles. The
migration voltage was fixed at 100 mV for all measure-
ments. The instrument was calibrated against 10-4 M AgI
colloidal dispersions. To measure the mean value of
nanoparticles core radius, Ultraviolet–Visible spectropho-
tometry was done.
Nanoparticle tracking analysis (NTA)
Nanoparticle tracking analysis measurements were done
with a NanoSight NS 300 (NanoSight, Malvern, United
Kingdom), equipped with a sample chamber with a
640-nm laser and a Viton fluoro-elastomer O-ring [18].
Using sterile syringes, requisite amount of samples was
injected in the sample chamber till the liquid reached the
tip of the nozzle. All measurements were performed at
room temperature. The software used for capturing and
analyzing the data was the NTA 2.0 Build 127. The
samples were measured for 40 s with manual shutter and
gain adjustments.
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Scanning electron microscopy
Scanning electron microscopy (SEM) was done to char-
acterize the morphology of the silver nanoparticles. The
silver nanoparticles were viewed with an EVO LS 10 (Carl
Zeiss, Brighton, Germany) scanning electron microscope
operating at an accelerating voltage of 13.52 kV under high
vacuum. Data analysis was done using Smart SEM soft-
ware program [19].
Antibacterial efficacy
Preparation of bacterial culture media
Appropriate amount of nutrient broth was dissolved
according to manufacturer’s instruction. Broth was auto-
claved at 121 C, 15 psi pressure for 20 min. Mother
inoculum of bacterial cultures was taken in 1:100 ratios and
added to the above sterile nutrient broth. The flask
was incubated overnight at 37 C in the orbital shaker
incubator. Next day turbidity of media indicated the growth
of the culture. Absorbance was measured at a 600 nm by
UV spectrophotometer and CFU/ml was calculated as a
ratio between the optical density and CFU/ml,
1OD = 0.8 9 109 CFU/ml.
Disc diffusion assay and analysis of growth curve
All the glassware and media used were sterilized in an
autoclave at 121 C for 20 min. The bacterial strains
E. coli (DH5a) and S. aureus were used as model test
strains for Gram-negative and Gram-positive bacteria. The
bacterial suspension was prepared in nutrient broth at
37 C overnight. The antibacterial susceptibility of AgNPs
was evaluated using the Kirby Bauer method. Bacterial
suspension was mixed with soft agar and poured on a LB
agar plate. The plates were then divided into sections and
sterile discs of 5 mm diameter were placed on each section
loaded with 20 ll of AgNPs [TSC-AgNPs (107.86 lg/ml)
and PVP-AgNPs (539.43 lg/ml)], Gentamycin (positive
control) and Distilled water (negative control); the plates
were further incubated overnight at 37 C. The zone of
inhibition (ZoI) was measured after 24 h.
Bacterial cultures were inoculated to the freshly pre-
pared nutrient broth by adding stock culture to Nutrient
broth in 1:100 ratios and kept in 37 C incubator for 24 h.
The different samples were prepared by adding the inoc-
ulated culture (100 ll) to the equally divided media, con-
trol (flask containing nutrient media, with only inoculum
and no AgNPs) and experimental flasks (flask containing
inoculum and nutrient media, with AgNPs). The absor-
bance values for experimental flasks (containing nutrient
media, inoculum and AgNPs) were corrected by deducting
the corresponding absorbance values for the control. Here,
antibacterial effects of AgNPs were studied using optical
intensity as function of time for 25 h for different size of
AgNPs.
Determination of MIC and MBC
To examine the minimum inhibitory concentration (MIC),
and minimum bactericidal concentration (MBC) of differ-
ent sized AgNPs, the procedure specified by Ruparelia
et al. [20] was followed. The effect of AgNPs on bacterial
growth kinetics was measured at 600 nm, as increase in
absorbance using a spectrophotometer. The experiment
included a positive control (flask containing AgNPs and
nutrient media, without inoculum) and a negative control
(flask containing inoculum and nutrient media, without
AgNPs). The absorbance values for experimental flasks
(containing nutrient media, inoculum and AgNPs) were
corrected by deducting the corresponding absorbance val-
ues for the positive controls. In this experiment we have
taken three concentrations of AgNPs, 13, 26.75, 53 lg/ml
and in case of PVP-AgNPs three concentrations are 67.3,
134.75, and 269.5 lg/ml.
DNA fragmentation assay
DNA damage study was performed using our previous
published protocol [21] on gram-negative bacteria, E. coli
and gram-positive bacteria S. aureus, after requisite treat-
ment with the prepared AgNPs. Briefly, the cells were
pelleted and resuspended in Glucose-Tris–EDTA buffer at
pH 8. Cells were lysed by addition of 1 % SDS. After
dissolving the lipid component of the cell envelope, NaCl
was added. Further, the cells were treated with phe-
nol:chloroform:isoamyl alcohol in the ratio of 25:24:1 that
helped in protein precipitation. The precipitate was col-
lected after discarding the supernatant. Isopropanol was
then added. To further remove the remaining salts and
SDS, the precipitate was washed with ethanol, and the
pellet was left overnight to dry. DNA was resolved and
electrophoresed in 1.5 % agarose gel at 60 V. The gel was
stained with ethidium bromide and the fragments of DNA
were observed in UV light.
Results
Characterization of silver nanoparticles
UV–Vis spectroscopy
In the UV–Vis spectra (Fig. 1), a single strong peak was
observed for citrate and PVP capped AgNPs at 415 and
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410 nm, respectively, which corresponds to the typical
surface plasmon resonance (SPR) of spherical AgNPs.
When compared to TSC, the SPR of PVP stabilized
nanoparticles has shown blue shift towards a shorter
wavelength of 410 nm. The shift in SPR is determined by
the capping agent due to the local nature of its effect on the
surface of the nanoparticles.
Dynamic light scattering
Dynamic light scattering was used to determine the size
distribution profile of nanoparticles in suspension. AgNPs
synthesized using TSC as a reducing and stabilizing agent
showed an average size of 34.01 nm with 0.42 PDI and
zeta potential -42.9 mV (Fig. 2a) and the average mean
size of PVP doped AgNPs was 54.09 nm with 0.64 PDI
and zeta potential -16.9 mV (Fig. 2b).
Nanoparticle tracking analysis (NTA)
Nanoparticle tracking analysis enables sample visualiza-
tion and provides approximate particle dispersion which is
very useful features. The images of NTA are shown in
Fig. 3. From the NTA data it is clear that the aggregation
between the particles is very less and particles are uni-
formly dispersed.
Fig. 1 UV–Vis spectra of
citrate and PVP doped AgNPs
Fig. 2 DLS measurements showing a TSC- AgNPs mean diameter (34.01 nm) with polydispersity index 0.426 and f = -42.9 mV. b PVP-
AgNPs mean diameter (54.09 nm) with polydispersity index 0.643 and f = -16.9 mV
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Scanning electron microscopy (SEM)
Scanning electron microscopy was done to confirm the size
and shape of silver nanoparticles. From the SEM images
shown in Fig. 4 it is clear that the particles are spherical in
shape and are below 100 nm in size. The PVP-AgNps are
slightly larger in size as compared to TSC-AgNPs.
Antibacterial efficacy
Disc diffusion assay
After 24 h of incubation the zones of growth inhibition
around each of the disc were measured to the nearest
millimeter. Highest ZoI (Table 1) was observed in TSC-
AgNPs followed by PVP doped AgNPs (Fig. 5). The
diameter of the zone is related to the susceptibility of the
isolate and to the diffusion rate of the TSC-AgNPs through
the agar medium. Hence, the clear zone of inhibition
around the TSC-AgNPs indicates its higher bactericidal
activity than PVP-AgNPs.
Absorbance value was taken at regular interval at
600 nm and a graph was plotted to examine the growth
inhibition by citrate and PVP coated AgNPs. TSC coated
AgNPs showed more bacterial growth inhibition than PVP-
AgNPs, which is exhibiting slight inhibition of bacterial
growth than control culture.
Determination of MIC and MBC
Absorbance value was taken at regular intervals at 600 nm
and a graph was plotted in the origin to examine the growth
inhibition by TSC-AgNPs (Fig. 6a) and PVP-AgNPs
(Fig. 6b).
MIC value (Table 2) for TSC-AgNPs is 26.75 lg/ml
and MBC (Table 2) value is 53 lg/ml. In case of PVP-
AgNPs MIC value is 269.5 lg/ml.
Fig. 3 NTA images of TSC-
AgNPs a and PVP-AgNPs
b. NTA images are clearly
showing the uniform dispersion
of prepared silver nanoparticles
Fig. 4 SEM images of TSC-
AgNPs a and PVP-AgNPs
b. SEM images are clearly
showing the size *100 nm and
spherical shape of the prepared
silver nanoparticles
Table 1 Antibacterial activity of silver nanoparticles on E. coli and
S. aureus
Sample Zone of inhibition (mm)
E. coli S. aureus
TSC-AgNO3 2 ± 0.34 3.5 ± 0.05
PVP-AgNO3 0.5 ± 0.12 2.5 ± 0.16
Gentamycin (1 mg/ml) 5 ± 0.22 6 ± 0.26
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DNA fragmentation assay
The gel clearly indicated the typical ladder in TSC-AgNPs
(Fig. 7). DNA damage was more visible in TSC-AgNPs
whereas no fragmentation was observed in PVP doped
AgNPs.
Discussion
With the increase in mutations of microbial organisms,
developing resistance to multiple antibiotics, and the con-
tinuing emphasis on health-care costs, many scientists
researchers are trying to develop novel, cost effective
antimicrobial agents. Such problems and needs have led to
the resurgence of finding a broad spectrum antiseptic
activity better than antibiotics [22].
The nanoparticles were prepared by modifying a rou-
tinely used method involving borohydride reduction of
silver nitrate in the presence of stabilizing agents. TSC-
AgNPs (34 nm) and PVP-AgNPs (54 nm) were synthe-
sized using different reducing and stabilizing agents, also
the zeta potential of both the nanoparticles was found to be
-42.9 and -16.9 mV, respectively. The decrease in zeta
potential from -42.9 to -16.9 mV in PVP-AgNPs is due
to the charge neutralization by capping of the silver
nanoparticles with PVP. Silver collide was directly used to
test the antibacterial activity so the concentration men-
tioned in the entire result was determined theoretically.
One of the important criterions for nanoparticle production
is the prevention of particle aggregation during synthesis.
The nanoparticles can be stabilized either by stearic or
electrostatic forces. The steric stabilization can be achieved
by doping polymers such as PVP, whereas the electrostatic
stabilization can be attained by surface modifiers such as
sodium borohydride and sodium citrate. AgNPs synthe-
sized using TSC as a reducing and stabilizing agent showed
higher antibacterial activity as compared to PVP-AgNPs.
From this result we can conclude that electrostatic stabi-
lization was more effective than steric stabilization.
Fig. 5 Antimicrobial activity of
silver nanoparticles against
a Gram-negative E. coli and
b Gram-positive S. aureus, (-)
negative control; distilled water,
(?) positive control;
Gentamycin
Fig. 6 Effect of different
AgNPs on a S. aureus and
b E. coli growth
Table 2 Determination of MIC
and MBC of silver nanoparticles
on E. coli and S. aureus
Sample E. coli S. aureus
MIC (lg/ml) MBC (lg/ml) MIC (lg/ml) MBC (lg/ml)
TSC-AgNO3 26.75 53 13.48 26.75
PVP-AgNO3 269.5 B269.5 67.41 134.83
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Further, the capping of the silver nanoparticles with PVP
resulted in the mild increase in the particle size of the silver
nanoparticles.
Nanoparticle tracking analysis, which was first com-
mercialized in 2006, is an innovative system for sizing
particles from about 30 to 1000 nm, with the lower
detection limit being dependent on the refractive index of
the nanoparticles. This technique combines laser light
scattering microscopy with a charge-coupled device (CCD)
camera, which enables the visualization and recording of
nanoparticles in solution. The NTA software is then able to
identify and track individual nanoparticles moving under
Brownian motion and relates the movement to a particle
size according to the following formula derived from the
Stokes–Einstein equation. One of the main constraints of
DLS is the impact that few large particles, such as dust,
may have on the average/mean size. The NTA technique is
based on the tracking of single particles, whereas DLS
measures a bulk of particles with a strong bias to the largest
particles present in the sample. Therefore, the performance
of NTA is expected to be less sensitive than DLS to the
presence of minute amounts of large particles. The influ-
ence of large particles on NTA and DLS results has been
summarized and reported earlier [18]. Furthermore, the
SEM results also confirm the size and spherical shape of
the nanoparticles.
Due to the smaller size of the AgNPs the surface area
was quite larger, hence the interaction with the bacterial
cell was probably more than PVP-AgNPs. In the recent
decades, nanoparticles have received considerable atten-
tion, largely due to their broad range of bioactivities and
distinctive mode of action [23].
Gel electrophoresis result also indicated that TSC-
AgNPs caused significant DNA fragmentation. The cause
of DNA damage can be explained by the mechanism of the
bactericidal effect of AgNPs. The reason for this size
dependency is probably a combination of the particles’
ability to react with and collectively penetrate the cell
membrane by the cumulative higher surface to volume
ratio of nanoparticles. It is well documented that Gram-
positive and Gram-negative bacteria have differences in
their membrane structure as the peptidoglycan layer is
thicker and contains Teichoic acid [23]. Therefore, the
efficacy of the Ag nanoparticles against S. aureus may be
due the difference in the membrane structure. To confirm
this hypothesis, further comparative study between various
gram-negative and gram-positive bacterial species was
done. Since the peptidoglycan layer is a specific feature of
bacteria and is not applicable to mammalian cells, then the
antibacterial effect of Ag nanoparticles must be associated
with the peptidoglycan layer. Therefore, the applications of
Ag nanoparticles as an antibacterial agent will be easier
and more specific to use as a textile coating, or coatings of
surgical instruments etc.
It is known that small (less than 5 nm) metallic particles
show electronic effects that are defined as changes in the
local electronic structure of the surface. These effects
enhance the reactivity of the nanoparticle surfaces.
Fig. 7 DNA fragmentation
assay, a Lane M 100 bp–3 Kbp
ladder, Lane 1 untreated E. coli
culture, Lane 2 E. coli treated
with PVP-AgNPs, Lane 3
E. coli treated with TSC-
AgNPs; b Lane M 250 bp–
25 Kbp ladder, Lane 1 untreated
S. aureus culture, Lane 2 S.
aureus treated with PVP-
AgNPs, Lane 3 S. aureus treated
with TSC-AgNPs
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Conclusion
The size of TSC-AgNPs was 34 nm and PVP-AgNO3 was
54 nm. Single SPR peak confirmed no aggregation occur-
red in both the synthesis process. The present study also
concluded that electrostatic stabilization was more effec-
tive than steric stabilization, hence citrate coated AgNPs
were smaller in size and have shown less polydispersity.
Moreover, AgNPs have also shown antibacterial activity
against E. coli and S. aureus as observed by the disc dif-
fusion assay and growth kinetics curve. Furthermore sig-
nificant DNA damage was possibly be due to interaction of
silver ions with the DNA of microorganism that leads to
the instability of DNA and thereby, interfering with its
ability to replicate. However, the exact molecular mecha-
nism of targeting is not fully understood; hence it warrants
further investigation into the molecular mechanism.
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